Gates Foundation Gives Group $28.5M For Microbicide Research, Officials Say
Main Category: HIV / AIDSAlso Included In: Biology / Biochemistry
Article Date: 05 Dec 2007 - 9:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
The Eastern Virginia Medical School in Norfolk, Va., on Friday announced that its Arlington, Va.-based CONRAD program has received a five-year, $28.5 million grant from the Bill & Melinda Gates Foundation to conduct microbicide research, the Newport News Daily Press reports (Flores, Newport News Daily Press, 12/1). Microbicides include a range of products -- such as gels, films and sponges -- that could help prevent the sexual transmission of HIV and other infections (Kaiser Daily HIV/AIDS Report, 2/20).
According to Gustavo Doncel, director of preclinical research for CONRAD, the grant will fund research on a new generation of microbicides that use antiretroviral drugs. Antiretrovirals when taken orally have been effective in treating HIV, but this research will test their efficacy when used in a topical vaginal gel that could prevent the sexual transmission of the virus, the Virginian-Pilot reports. CONRAD Executive Director Henry Gabelnick said that the development of a microbicide is important because women are especially vulnerable to HIV transmission through sexual activity. "It's clear that women are the majority of the new cases of HIV-positive people," Gabelnick said, adding, "If their partners won't use condoms, this gives women a product that they can use to protect themselves."
There are currently no microbicides on the market, but some have made it into the later stages of clinical trials, the Pilot reports. "The virus is much sneakier and cheekier than what we thought it would be," Doncel said. CONRAD is "poised to deliver something that is significant in the area of HIV prevention," Doncel added (Young, Virginian-Pilot, 12/1). The Gates Foundation to date has donated $65 million to CONRAD for microbicide research (Newport News Daily Press, 12/1).
Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our hiv / aids section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/90740.php>
APA
http://www.medicalnewstoday.com/releases/90740.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



